Page 137 - 《中国药房》2024年1期
P. 137

ischemia-reperfusion  injury (MIRI)[J].  Biomater  Sci,  [14]  ZHANG X Y,YU Y H,LEI H Y,et al. The Nrf-2/HO-1
              2022,10(21):6258-6266.                              signaling axis:a ray of hope in cardiovascular diseases[J].
          [ 2 ]  YANG Y,MA M Q,SU J N,et al. Acetylation,ferropto‐  Cardiol Res Pract,2020,2020:5695723.
              sis,and their potential relationships:implications in myo‐  [15]  蒋志明,张辽,刘磊,等. 电针心经激活核因子E2相关因
              cardial  ischemia-reperfusion  injury[J].  Am  J  Med  Sci,  子 2/血红素氧合酶信号通路抑制铁死亡改善急性心肌
              2023,366(3):176-184.                                缺血[J]. 针刺研究,2023,48(5):461-468.
          [ 3 ]  CHANG C,CAI R P,SU Y M,et al. Mesenchymal stem   JIANG Z M,ZHANG L,LIU L,et al. Electroacupuncture
              cell-derived  exosomal  noncoding  RNAs  as  alternative   improves  ischemic  myocardial  injury  by  activating  Nrf2/
              treatments  for  myocardial  ischemia-reperfusion  injury:  HO-1  signaling  pathway  to  inhibit  ferroptosis  in  rats[J].
              current  status  and  future  perspectives[J].  J  Cardiovasc   Acupunct Res,2023,48(5):461-468.
              Transl Res,2023,16(5):1085-1098.               [16]  XIA  J Y,CHEN  C,LIN  Q,et  al.  Role  of  mitophagy  in
          [ 4 ]  ZHANG  Q,LIU  J,DUAN  H,et  al. Activation  of  Nrf2/  myocardial ischemia/reperfusion injury and Chinese medi‐
              HO-1  signaling:an  important  molecular  mechanism  of   cine treatment[J]. Chin J Integr Med,2023,29(1):81-88.
              herbal medicine in the treatment of atherosclerosis via the   [17]  陈中青,侯丹丹,王伟 . 瑞芬太尼通过核因子 E2 相关因
              protection  of  vascular  endothelial  cells  from  oxidative   子通路增强自噬改善大鼠心肌缺血再灌注损伤的研究
              stress[J]. J Adv Res,2021,34:43-63.                 [J]. 中国临床药理学杂志,2023,39(1):47-51.
          [ 5 ]  LI S,YANG K,CAO W L,et al. Tanshinone ⅡA enhances   CHEN Z Q,HOU D D,WANG W. Remifentanil against
              the  therapeutic  efficacy  of  mesenchymal  stem  cells  de‐  myocardial ischemia-reperfusion injury by enhancing au‐
              rived exosomes in myocardial ischemia/reperfusion injury   tophagy via the activation of nuclear factor erythroid 2-re‐
              via up-regulating miR-223-5p[J]. J Control Release,2023,  lated factor 2 pathway in rat model[J]. Chin J Clin Phar‐
              358:13-26.                                          macol,2023,39(1):47-51.
          [ 6 ]  WU Z Y,YANG Z X,LIU L Y,et al. Natural compounds   [18]  O’DONNELL A,PEPPER C,MITCHELL S,et al. NF-
              protect against the pathogenesis of osteoarthritis by media-   κB and the CLL microenvironment[J]. Front Oncol,2023,
              ting  the  Nrf2/ARE  signaling[J].  Front  Pharmacol,2023,  13:1169397.
              14:1188215.                                    [19]  ZHANG Z Y,YAN B F,LI Y G,et al. Propofol inhibits
          [ 7 ]  TONELLI  C,CHIO  I  I  C,TUVESON  D  A.  Transcrip‐  oxidative  stress  injury  through  the  glycogen  synthase  ki‐
              tional regulation by Nrf2[J]. Antioxid Redox Signal,2018,  nase  3  beta/nuclear  factor  erythroid  2-related  factor  2/
              29(17):1727-1745.                                   heme  oxygenase-1  signaling  pathway[J].  Bioengineered,
          [ 8 ]  SANI G,MARGONI S,BRUGNAMI A,et al. The Nrf2      2022,13(1):1612-1625.
              pathway  in  depressive  disorders:a  systematic  review  of   [20]  WANG R,WU Y G,JIANG S T. FOXC2 alleviates myo‐
              animal  and  human  studies[J].  Antioxidants,2023,12  cardial ischemia-reperfusion injury in rats through regula-
              (4):817.                                            ting Nrf2/HO-1 signaling pathway[J]. Dis Markers,2021,
          [ 9 ]  SONI D,KUMAR P. GSK-3β-mediated regulation of    2021:9628521.
              Nrf2/HO-1 signaling as a new therapeutic approach in the   [21]  董莉,杨燕玲,郑钰凡,等. 益心方调控SIRT1/PGC-1α信
              treatment  of  movement  disorders[J].  Pharmacol  Rep,  号通路改善大鼠心肌缺血再灌注损伤[J]. 上海中医药杂
              2022,74(4):557-569.                                 志,2023,57(7):58-65.
          [10]  LEAL E C,CARVALHO E. Heme oxygenase-1 as thera‐   DONG L,YANG Y L,ZHENG Y F,et al. Yixin formula
              peutic  target  for  diabetic  foot  ulcers[J].  Int  J  Mol  Sci,  modulates  SIRT1/PGC-1α  signaling  pathway  to  improve
              2022,23(19):12043.                                  myocardial ischemia-reperfusion injury in rats[J]. Shanghai
          [11]  XU J J,ZHU K Y,WANG Y L,et al. The dual role and   J Tradit Chin Med,2023,57(7):58-65.
              mutual dependence of heme/HO-1/Bach1 axis in the carci‐  [22]  马艺华,石月萍 . 温阳通脉方通过 Nrf2/HO-1 通路对缺
              nogenic  and  anti-carcinogenic  intersection[J].  J  Cancer   氧/复氧损伤H9c2心肌细胞氧化应激的保护作用[J]. 中
              Res Clin Oncol,2023,149(1):483-501.                 药药理与临床,2022,38(5):73-77.
          [12]  MANSOURI A,REINER Ž,RUSCICA M,et al. Antioxi‐     MA Y H,SHI Y P. Protective effect of Wenyang tongmai
              dant effects of statins by modulating Nrf2 and Nrf2/HO-1   recipe on oxidative stress of H9c2 cardiomyocytes injured
              signaling  in  different  diseases[J].  J  Clin  Med,2022,11  by hypoxia/reoxygenation through Nrf2/HO-1 pathway[J].
              (5):1313.                                           Pharmacol Clin Chin Mater Med,2022,38(5):73-77.
          [13]  FENG S L,LI Y T,HUANG  H H,et al. Isoorientin re‐  [23]  刘晓瑜,顾民华,徐煜凌,等 . 定心方Ⅰ号方通过调控
              verses lung cancer drug resistance by promoting ferropto‐  GSK3β/Nrf2/HO-1 通路防治大鼠心肌缺血再灌注损伤
              sis via the SIRT6/Nrf2/GPX4 signaling pathway[J]. Eur J   的机制研究[J]. 中药新药与临床药理,2020,31(11):
              Pharmacol,2023,954:175853.                          1265-1270.


          中国药房  2024年第35卷第1期                                                 China Pharmacy  2024 Vol. 35  No. 1    · 127 ·
   132   133   134   135   136   137   138   139   140   141   142